# V12.2 Final Remediation Summary

## Objective

Defect-remediation release: close known high-risk V12 defects, add the newly found laboratory plausibility guard, remove artificial content-blocking from product testing through explicitly synthetic institutional templates, and rerun the complete requested executable test sequence.

## Final fresh run

- **38 / 38** targeted remediation checks passed.
- **48 / 48** V12 process/IPD checks passed.
- **94 / 94** regression checks passed.
- **41 / 41** supplied process scenarios passed using synthetic institutional content.
- Scenario preflight failures: **0**.
- Scenario audit-chain errors: **0**.

## Synthetic institutional content

For product testing/demo only:

- 21 orderable systemic-regimen templates;
- 16 RT templates;
- 14 surgery templates;
- 2 continuous-therapy templates;
- 5 test formulary items;
- plus existing synthetic TCHP demo regimen.

No clinical correctness claim is made for these synthetic templates.

## Important closed defect: lab plausibility

Impossible values are rejected before Final result persistence. The acceptance suite specifically tests `999999` and `350 ×10^9/L` ANC rejection, normal `3.5 ×10^9/L` acceptance, and `800 cells/µL` canonical normalization for readiness.

## Canonical scenario runner

`v12_2_synthetic_41_case_runner.py` is the canonical 41-case runner. `v12_2_41_case_runner.py` is retained only as a compatibility entry point and delegates to the canonical runner.

## Interpretation

The release has **zero observed failures across the requested executable acceptance suites**. This is not a claim that software can never contain a defect, nor a claim of production clinical/regulatory readiness. Full browser interaction was environment-blocked; live external integrations and real institutional clinical-content sign-off remain separate gates.
